Prestige Financial Statements From 2010 to 2024
| 334970 Stock | KRW 5,100 100.00 1.92% |
Check Prestige Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Prestige Biologics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Prestige financial statements analysis is a perfect complement when working with Prestige Biologics Valuation or Volatility modules.
Prestige |
Prestige Biologics Co Company EBITDA Analysis
Prestige Biologics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Prestige Biologics EBITDA | (12.84 B) |
Most of Prestige Biologics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Prestige Biologics Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Prestige Biologics Co reported earnings before interest,tax, depreciation and amortization of (12.84 Billion). This is 1563.91% lower than that of the Healthcare sector and significantly lower than that of the Biotechnology industry. The ebitda for all Republic of Korea stocks is significantly higher than that of the company.
Prestige Biologics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Prestige Biologics's current stock value. Our valuation model uses many indicators to compare Prestige Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Prestige Biologics competition to find correlations between indicators driving Prestige Biologics's intrinsic value. More Info.Prestige Biologics Co is rated below average in return on equity category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Prestige Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Prestige Biologics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Prestige Biologics Financial Statements
Prestige Biologics stakeholders use historical fundamental indicators, such as Prestige Biologics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Prestige Biologics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Prestige Biologics' assets and liabilities are reflected in the revenues and expenses on Prestige Biologics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Prestige Biologics Co. Please read more on our technical analysis and fundamental analysis pages.
Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars. The company was founded in 2015 and is based in Cheongju-si, South Korea. Prestige Biologics is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with Prestige Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Prestige Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with Prestige Stock
| 0.61 | 207940 | Samsung Biologics | PairCorr |
| 0.83 | 326030 | Sk Biopharmaceuticals | PairCorr |
| 0.83 | 298380 | ABL Bio | PairCorr |
| 0.87 | 144510 | Green Cross Lab | PairCorr |
Moving against Prestige Stock
The ability to find closely correlated positions to Prestige Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Prestige Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Prestige Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Prestige Biologics Co to buy it.
The correlation of Prestige Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Prestige Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Prestige Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Prestige Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Prestige Stock
Prestige Biologics financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Biologics security.